THE TREATMENT OF REFRACTORY DEPRESSION USING PAROXETINE WITH LITHIUM AUGMENTATION

被引：5
|
作者：
CAMPRUBI, ME
PURI, BK
机构：
[1] Department of Psychiatry, Charing Cross Hospital, London, England
来源：
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 1995年 / 19卷 / 03期
关键词：
LITHIUM; MAJOR DEPRESSION; PAROXETINE; TREATMENT RESISTANCE;
D O I：
10.1016/0278-5846(95)00032-Q
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1. The case is described of a 68-year-old woman with DSM-III-R major depression who was treatment-resistant to paroxetine. 2. Low dose lithium addition, at a plasma level of 0.2 mM, led to a rapid and sustained remission of her illness.
引用
收藏
页码：515 / 517
页数：3
相关论文
共 50 条
  • [41] LITHIUM AUGMENTATION OF VALPROIC ACID IN TREATMENT-RESISTANT DEPRESSION
    SHARMA, V
    PERSAD, E
    KUENEMAN, K
    MAZMANIAN, D
    WADDEN, P
    LITHIUM, 1994, 5 (02): : 99 - 103
  • [42] Quetiapine augmentation of treatment-resistant depression:: a comparison with lithium
    Doree, Jean-Pierre
    Rosiers, Joel Des
    Lew, Viviane
    Gendron, Alain
    Elie, Robert
    Stip, Emmanuel
    Tourjman, S. Valerie
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (02) : 333 - 341
  • [43] Predictors of efficacy in lithium augmentation for treatment-resistant depression
    Sugawara, Hiroko
    Sakamoto, Kaoru
    Harada, Tsuyoto
    Ishigooka, Jun
    JOURNAL OF AFFECTIVE DISORDERS, 2010, 125 (1-3) : 165 - 168
  • [44] LITHIUM AUGMENTATION IN GERIATRIC DEPRESSION
    VANMARWIJK, HWJ
    BEKKER, FM
    NOLEN, WA
    JANSEN, PAF
    VANNIEUWKERK, JF
    HOP, WCJ
    JOURNAL OF AFFECTIVE DISORDERS, 1990, 20 (04) : 217 - 223
  • [45] Lithium augmentation in milnacipran-refractory depression for the prevention of relapse following electroconvulsive therapy
    Okamoto, H
    Shimizu, E
    Ozawa, K
    Hashimoto, K
    Iyo, M
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2005, 39 (1-2): : 108 - 108
  • [46] Venlafaxine augmentation with methylphenidate for treatment-refractory depression: A case report
    Bader, GM
    Hawley, JM
    Short, DD
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (03) : 255 - 256
  • [47] Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder
    D'Amico, G
    Cedro, C
    Muscatello, MR
    Pandolfo, G
    Di Rosa, AE
    Zoccali, R
    La Torre, D
    D'Arrigo, C
    Spina, E
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (04): : 619 - 623
  • [48] Treatment of resistant depression by adding noradrenergic agents to lithium augmentation of SSRIs
    Ramasubbu, R
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (04) : 634 - 640
  • [49] LITHIUM AUGMENTATION OF COMBINED NEUROLEPTIC-TRICYCLIC TREATMENT IN DELUSIONAL DEPRESSION
    PRICE, LH
    CONWELL, Y
    NELSON, JC
    AMERICAN JOURNAL OF PSYCHIATRY, 1983, 140 (03): : 318 - 322
  • [50] POLYGENIC PREDICTORS OF TREATMENT OUTCOME FOLLOWING LITHIUM AUGMENTATION IN MAJOR DEPRESSION
    Kraft, Julia
    Ricken, Roland
    Braun, Alice
    Ripke, Stephan
    Buspavanich, Pichit
    Adli, Mazda
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 51 : E181 - E181
12345